Felix Salmon, writing for Wired:
It's like British cyclist Tom Simpson, who took a combination of cognac and amphetamines before a brutally hot stage of the 1967 Tour de France. It enabled him to push past his limits-until he collapsed and died on the slopes of Mount Ventoux. Sometimes it's best to conserve energy, to play the long game, and not to risk everything for the sake of a short-term win. But once you're public, the markets start pushing you to hit those numbers every quarter. And the results can be fatal.
In the context of secondary markets and IPOs, drug-addled Tour de France riders make perfect sense. That and I'm a sucker for an awesome segue.